Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site

Brooke L. Brewster, Francesca Rossiello, Juliet D. French, Stacey L. Edwards, Ming Wong, Ania Wronski, Phillip Whiley, Nic Waddell, Xiaowei Chen, Betsy Bove, [No Value] KconFab, John L. Hopper, Esther M. John, Irene Andrulis, Mary Daly, Sara Volorio, Loris Bernard, Bernard Peissel, Siranoush Manoukian, Monica BarileSara Pizzamiglio, Paolo Verderio, Amanda B. Spurdle, Paolo Radice, Andrew K. Godwin, Melissa C. Southey, Melissa A. Brown, Paolo Peterlongo

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Mutations in the BRCA1 gene confer a substantial increase in breast cancer risk, yet routine clinical genetic screening is limited to the coding regions and intron-exon boundaries, precluding the identification of mutations in noncoding and untranslated regions (UTR). As 3′UTR mutations can influence cancer susceptibility by altering protein and microRNA (miRNA) binding regions, we screened the BRCA1 3′UTR for mutations in a large series of BRCA-mutation negative, population and clinic-based breast cancer cases, and controls. Fifteen novel BRCA1 3′UTR variants were identified, the majority of which were unique to either cases or controls. Using luciferase reporter assays, three variants found in cases, c.*528G>C, c.*718A>G, and c.*1271T>C and four found in controls, c.*309T>C, c.*379G>A, c.*823C>T, and c.*264C>T, reduced 3′UTR activity (P <0.02), whereas two variants found in cases, c.*291C>T and c.*1139G>T, increased 3′UTR activity (P <0.01). Three case variants, c.*718A>G, c.*800T>C, and c.*1340_1342delTGT, were predicted to create new miRNA binding sites and c.*1340_1342delTGT caused a reduction (25%, P = 0.0007) in 3′UTR reporter activity when coexpressed with the predicted targeting miRNA, miR-103. This is the most comprehensive identification and analysis of BRCA1 3′UTR variants published to date.

Original languageEnglish
Pages (from-to)1665-1675
Number of pages11
JournalHuman Mutation
Volume33
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Breast Neoplasms
Mutation
MicroRNAs
BRCA1 Gene
Untranslated Regions
Genetic Testing
Luciferases
Protein Binding
Introns
Exons
Binding Sites
Population
Neoplasms

Keywords

  • 3′UTR
  • BRCA1
  • Breast cancer
  • MicroRNAs

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. / Brewster, Brooke L.; Rossiello, Francesca; French, Juliet D.; Edwards, Stacey L.; Wong, Ming; Wronski, Ania; Whiley, Phillip; Waddell, Nic; Chen, Xiaowei; Bove, Betsy; KconFab, [No Value]; Hopper, John L.; John, Esther M.; Andrulis, Irene; Daly, Mary; Volorio, Sara; Bernard, Loris; Peissel, Bernard; Manoukian, Siranoush; Barile, Monica; Pizzamiglio, Sara; Verderio, Paolo; Spurdle, Amanda B.; Radice, Paolo; Godwin, Andrew K.; Southey, Melissa C.; Brown, Melissa A.; Peterlongo, Paolo.

In: Human Mutation, Vol. 33, No. 12, 12.2012, p. 1665-1675.

Research output: Contribution to journalArticle

Brewster, BL, Rossiello, F, French, JD, Edwards, SL, Wong, M, Wronski, A, Whiley, P, Waddell, N, Chen, X, Bove, B, KconFab, NV, Hopper, JL, John, EM, Andrulis, I, Daly, M, Volorio, S, Bernard, L, Peissel, B, Manoukian, S, Barile, M, Pizzamiglio, S, Verderio, P, Spurdle, AB, Radice, P, Godwin, AK, Southey, MC, Brown, MA & Peterlongo, P 2012, 'Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site', Human Mutation, vol. 33, no. 12, pp. 1665-1675. https://doi.org/10.1002/humu.22159
Brewster, Brooke L. ; Rossiello, Francesca ; French, Juliet D. ; Edwards, Stacey L. ; Wong, Ming ; Wronski, Ania ; Whiley, Phillip ; Waddell, Nic ; Chen, Xiaowei ; Bove, Betsy ; KconFab, [No Value] ; Hopper, John L. ; John, Esther M. ; Andrulis, Irene ; Daly, Mary ; Volorio, Sara ; Bernard, Loris ; Peissel, Bernard ; Manoukian, Siranoush ; Barile, Monica ; Pizzamiglio, Sara ; Verderio, Paolo ; Spurdle, Amanda B. ; Radice, Paolo ; Godwin, Andrew K. ; Southey, Melissa C. ; Brown, Melissa A. ; Peterlongo, Paolo. / Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. In: Human Mutation. 2012 ; Vol. 33, No. 12. pp. 1665-1675.
@article{b568e76eefcc4ad7a16b815932fa7dd6,
title = "Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site",
abstract = "Mutations in the BRCA1 gene confer a substantial increase in breast cancer risk, yet routine clinical genetic screening is limited to the coding regions and intron-exon boundaries, precluding the identification of mutations in noncoding and untranslated regions (UTR). As 3′UTR mutations can influence cancer susceptibility by altering protein and microRNA (miRNA) binding regions, we screened the BRCA1 3′UTR for mutations in a large series of BRCA-mutation negative, population and clinic-based breast cancer cases, and controls. Fifteen novel BRCA1 3′UTR variants were identified, the majority of which were unique to either cases or controls. Using luciferase reporter assays, three variants found in cases, c.*528G>C, c.*718A>G, and c.*1271T>C and four found in controls, c.*309T>C, c.*379G>A, c.*823C>T, and c.*264C>T, reduced 3′UTR activity (P <0.02), whereas two variants found in cases, c.*291C>T and c.*1139G>T, increased 3′UTR activity (P <0.01). Three case variants, c.*718A>G, c.*800T>C, and c.*1340_1342delTGT, were predicted to create new miRNA binding sites and c.*1340_1342delTGT caused a reduction (25{\%}, P = 0.0007) in 3′UTR reporter activity when coexpressed with the predicted targeting miRNA, miR-103. This is the most comprehensive identification and analysis of BRCA1 3′UTR variants published to date.",
keywords = "3′UTR, BRCA1, Breast cancer, MicroRNAs",
author = "Brewster, {Brooke L.} and Francesca Rossiello and French, {Juliet D.} and Edwards, {Stacey L.} and Ming Wong and Ania Wronski and Phillip Whiley and Nic Waddell and Xiaowei Chen and Betsy Bove and KconFab, {[No Value]} and Hopper, {John L.} and John, {Esther M.} and Irene Andrulis and Mary Daly and Sara Volorio and Loris Bernard and Bernard Peissel and Siranoush Manoukian and Monica Barile and Sara Pizzamiglio and Paolo Verderio and Spurdle, {Amanda B.} and Paolo Radice and Godwin, {Andrew K.} and Southey, {Melissa C.} and Brown, {Melissa A.} and Paolo Peterlongo",
year = "2012",
month = "12",
doi = "10.1002/humu.22159",
language = "English",
volume = "33",
pages = "1665--1675",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site

AU - Brewster, Brooke L.

AU - Rossiello, Francesca

AU - French, Juliet D.

AU - Edwards, Stacey L.

AU - Wong, Ming

AU - Wronski, Ania

AU - Whiley, Phillip

AU - Waddell, Nic

AU - Chen, Xiaowei

AU - Bove, Betsy

AU - KconFab, [No Value]

AU - Hopper, John L.

AU - John, Esther M.

AU - Andrulis, Irene

AU - Daly, Mary

AU - Volorio, Sara

AU - Bernard, Loris

AU - Peissel, Bernard

AU - Manoukian, Siranoush

AU - Barile, Monica

AU - Pizzamiglio, Sara

AU - Verderio, Paolo

AU - Spurdle, Amanda B.

AU - Radice, Paolo

AU - Godwin, Andrew K.

AU - Southey, Melissa C.

AU - Brown, Melissa A.

AU - Peterlongo, Paolo

PY - 2012/12

Y1 - 2012/12

N2 - Mutations in the BRCA1 gene confer a substantial increase in breast cancer risk, yet routine clinical genetic screening is limited to the coding regions and intron-exon boundaries, precluding the identification of mutations in noncoding and untranslated regions (UTR). As 3′UTR mutations can influence cancer susceptibility by altering protein and microRNA (miRNA) binding regions, we screened the BRCA1 3′UTR for mutations in a large series of BRCA-mutation negative, population and clinic-based breast cancer cases, and controls. Fifteen novel BRCA1 3′UTR variants were identified, the majority of which were unique to either cases or controls. Using luciferase reporter assays, three variants found in cases, c.*528G>C, c.*718A>G, and c.*1271T>C and four found in controls, c.*309T>C, c.*379G>A, c.*823C>T, and c.*264C>T, reduced 3′UTR activity (P <0.02), whereas two variants found in cases, c.*291C>T and c.*1139G>T, increased 3′UTR activity (P <0.01). Three case variants, c.*718A>G, c.*800T>C, and c.*1340_1342delTGT, were predicted to create new miRNA binding sites and c.*1340_1342delTGT caused a reduction (25%, P = 0.0007) in 3′UTR reporter activity when coexpressed with the predicted targeting miRNA, miR-103. This is the most comprehensive identification and analysis of BRCA1 3′UTR variants published to date.

AB - Mutations in the BRCA1 gene confer a substantial increase in breast cancer risk, yet routine clinical genetic screening is limited to the coding regions and intron-exon boundaries, precluding the identification of mutations in noncoding and untranslated regions (UTR). As 3′UTR mutations can influence cancer susceptibility by altering protein and microRNA (miRNA) binding regions, we screened the BRCA1 3′UTR for mutations in a large series of BRCA-mutation negative, population and clinic-based breast cancer cases, and controls. Fifteen novel BRCA1 3′UTR variants were identified, the majority of which were unique to either cases or controls. Using luciferase reporter assays, three variants found in cases, c.*528G>C, c.*718A>G, and c.*1271T>C and four found in controls, c.*309T>C, c.*379G>A, c.*823C>T, and c.*264C>T, reduced 3′UTR activity (P <0.02), whereas two variants found in cases, c.*291C>T and c.*1139G>T, increased 3′UTR activity (P <0.01). Three case variants, c.*718A>G, c.*800T>C, and c.*1340_1342delTGT, were predicted to create new miRNA binding sites and c.*1340_1342delTGT caused a reduction (25%, P = 0.0007) in 3′UTR reporter activity when coexpressed with the predicted targeting miRNA, miR-103. This is the most comprehensive identification and analysis of BRCA1 3′UTR variants published to date.

KW - 3′UTR

KW - BRCA1

KW - Breast cancer

KW - MicroRNAs

UR - http://www.scopus.com/inward/record.url?scp=84869087925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869087925&partnerID=8YFLogxK

U2 - 10.1002/humu.22159

DO - 10.1002/humu.22159

M3 - Article

C2 - 22753153

AN - SCOPUS:84869087925

VL - 33

SP - 1665

EP - 1675

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 12

ER -